subscribeSubscribe
BMS touts KRAS confirmatory trial win after Amgen`s stumble

BMS touts KRAS confirmatory trial win after Amgen`s stumble
Angus Liu FIERCE PHARMA
30 Mar 2024
Share Share
Verastem Granted Fast Track Designation for Avutometinib and Sotorasib

Verastem Granted Fast Track Designation for Avutometinib and Sotorasib
BUSINESSWIRE
18 Jan 2024
Share Share
FDA declines to grant Amgen’s Lumakras full approval in lung cancer

FDA declines to grant Amgen’s Lumakras full approval in lung cancer
ENDPTS
27 Dec 2023
Share Share
Amgen sticks by Lumakras dose as ESMO data boost confidence

Amgen sticks by Lumakras dose as ESMO data boost confidence
Max Bayer FIERCE PHARMA
22 Oct 2023
Share Share
Verastem Announces Results of RAMP 203 Trial of Avutometinib and LUMAKRAS

Verastem Announces Results of RAMP 203 Trial of Avutometinib and LUMAKRAS
BUSINESSWIRE
14 Oct 2023
Share Share
US FDA panel says Amgen lung cancer drug data cannot be relied on

US FDA panel says Amgen lung cancer drug data cannot be relied on
REUTERS
06 Oct 2023
Share Share
Amgen`s late-stage data for lung cancer drug `not adequate` - FDA staff

Amgen`s late-stage data for lung cancer drug `not adequate` - FDA staff
REUTERS
04 Oct 2023
Share Share
FDA flags `systemic bias` in Amgen`s Lumakras trial

FDA flags `systemic bias` in Amgen`s Lumakras trial
Zoey Becker FIERCE PHARMA
03 Oct 2023
Share Share
Amgen Presents Lumakras Plus Chemotherapy Data In First-Line Kras G12C Nsclc

Amgen Presents Lumakras Plus Chemotherapy Data In First-Line Kras G12C Nsclc
PR NEWSWIRE
10 Sep 2023
Share Share
Bazhenova Details Potential Pathways Forward for Targeting KRAS in NSCLC

Bazhenova Details Potential Pathways Forward for Targeting KRAS in NSCLC
ONCLIVE
28 Aug 2023
Share Share